Beacon Pharmaceuticals Temettü
Temettü kriter kontrolleri 2/6
Beacon Pharmaceuticals is a dividend paying company with a current yield of 1.66% that is well covered by earnings. Next payment date is on 22nd January, 2025 with an ex-dividend date of 28th October, 2024.
Anahtar bilgiler
1.7%
Temettü verimi
n/a
Geri Alım Getirisi
| Toplam Hissedar Getirisi | n/a |
| Gelecekteki Temettü Verimi | n/a |
| Temettü Büyümesi | -10.4% |
| Bir sonraki temettü ödeme tarihi | 22 Jan 25 |
| Eski temettü tarihi | 28 Oct 24 |
| Hisse başına temettü | ৳2.000 |
| Ödeme oranı | 56% |
Son temettü güncellemeleri
Recent updates
Ödemelerde İstikrar ve Büyüme
Temettü verilerini getirme
İstikrarlı Temettü: Whilst dividend payments have been stable, BEACONPHAR has been paying a dividend for less than 10 years.
Büyüyen Temettü: BEACONPHAR's dividend payments have increased, but the company has only paid a dividend for 8 years.
Piyasaya Karşı Temettü Getirisi
| Beacon Pharmaceuticals Piyasaya Karşı Temettü Getirisi |
|---|
| Segment | Temettü Verimi |
|---|---|
| Şirket (BEACONPHAR) | 1.7% |
| Pazarın Alt %25'i (BD) | 1.2% |
| Pazarın En İyi %25'i (BD) | 4.7% |
| Sektör Ortalaması (Pharmaceuticals) | 3.8% |
| Analist tahmini (BEACONPHAR) (3 yıla kadar) | n/a |
Önemli Temettü: BEACONPHAR's dividend (1.66%) is higher than the bottom 25% of dividend payers in the BD market (1.22%).
Yüksek Temettü: BEACONPHAR's dividend (1.66%) is low compared to the top 25% of dividend payers in the BD market (4.65%).
Hissedarlara Ödenen Kazanç
Kazanç Kapsamı: With its reasonable payout ratio (55.8%), BEACONPHAR's dividend payments are covered by earnings.
Hissedarlara Nakit Ödeme
Nakit Akışı Kapsamı: BEACONPHAR is paying a dividend but the company has no free cash flows.